Cite

    Robin Marlow et al.. “A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.” Vaccine, vol. 36, no. 17, 2018, pp. 2300–2306. http://access.bl.uk/ark:/81055/vdc_100059393366.0x00003f